Diagnostic biomarkers in tear fluid: from sampling to preanalytical processing

by Franziska Bachhuber, André Huss, Makbule Senel, Hayrettin Tumani
Published 2021-05-01

Emotional Components of Pain Perception in Borderline Personality Disorder and Major Depression—A Repetitive Peripheral Magnetic Stimulation (rPMS) Study

by Kathrin Malejko, André Huss, Carlos Schönfeldt-Lecuona, Maren Braun, Heiko Graf
Published 2020-11-01

Longitudinal Serum Neurofilament Levels of Multiple Sclerosis Patients Before and After Treatment with First-Line Immunomodulatory Therapies

by André Huss, Makbule Senel, Ahmed Abdelhak, Benjamin Mayer, Jan Kassubek, Albert C. Ludolph, Markus Otto, Hayrettin Tumani
Published 2020-08-01

A Score Based on NfL and Glial Markers May Differentiate Between Relapsing–Remitting and Progressive MS Course

by André Huss, Markus Otto, Makbule Senel, Albert C. Ludolph, Ahmed Abdelhak, Ahmed Abdelhak, Hayrettin Tumani, Hayrettin Tumani
Published 2020-07-01

Cerebrospinal Fluid Biomarkers in Relation to MRZ Reaction Status in Primary Progressive Multiple Sclerosis

by Tilman Robinson, Ahmed Abdelhak, Tanima Bose, Edgar Meinl, Markus Otto, Uwe K. Zettl, Rick Dersch, Hayrettin Tumani, Sebastian Rauer, André Huss
Published 2020-11-01

CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia

by Samir Abu-Rumeileh, Petra Steinacker, Barbara Polischi, Angela Mammana, Anna Bartoletti-Stella, Patrick Oeckl, Simone Baiardi, Corrado Zenesini, André Huss, Pietro Cortelli, Sabina Capellari, Markus Otto, Piero Parchi
Published 2019-12-01

Explorative study of emerging blood biomarkers in progressive multiple sclerosis (EmBioProMS): Design of a prospective observational multicentre pilot study

by Ahmed Abdelhak, Andre Huss, Alexander Stahmann, Makbule Senel, Markus Krumbholz, Markus C. Kowarik, Joachim Havla, Tania Kümpfel, Ingo Kleiter, Isabella Wüstinger, Uwe K. Zettl, Margit Schwartz, Romy Roesler, Tim Friede, Albert C. Ludolph, Ulf Ziemann, Hayrettin Tumani
Published 2020-06-01

Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker?

by Ahmed Abdelhak, Ahmed Abdelhak, Tilman Hottenrott, Estrella Morenas-Rodríguez, Estrella Morenas-Rodríguez, Marc Suárez-Calvet, Uwe K. Zettl, Christian Haass, Christian Haass, Christian Haass, Sven G. Meuth, Sebastian Rauer, Markus Otto, Hayrettin Tumani, Hayrettin Tumani, André Huss
Published 2019-03-01